论文信息 - A therapeutic challenge: catastrophic anti-phospholipid syndrome with diffuse alveolar haemorrhage - 字舞流文

A therapeutic challenge: catastrophic anti-phospholipid syndrome with diffuse alveolar haemorrhage

N. Martis | J. Dellamonica | D. Doyen | G. Bernardin | H. Hyvernat | S. Lechtman | E. Blanchouin | A. Robert | R. Lazdunski

[1] H. Garchon,et al. Revisiting MHC Genes in Spondyloarthritis , 2015, Current Rheumatology Reports.

[2] S. Zuily,et al. The Challenge of Bleeding in Antiphospholipid Antibody-Positive Patients , 2015, Current Rheumatology Reports.

[3] Y. Shoenfeld,et al. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. , 2014, Autoimmunity reviews.

[4] A. Ashrani,et al. Primary Antiphospholipid Syndrome–Associated Diffuse Alveolar Hemorrhage , 2014, Arthritis care & research.

[5] Y. Shoenfeld,et al. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. , 2013, Autoimmunity reviews.

[6] H. Collard,et al. Diffuse alveolar hemorrhage. , 2004, Clinics in chest medicine.

[7] Y. Shoenfeld,et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines , 2003, Lupus.